HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/5/H1740    most recent 00904.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Qian, J.-Y. Articles by LaPointe, M. C. Search for Related Content PubMed PubMed Citation Articles by Qian, J.-Y. Articles by LaPointe, M. C.

CALL FOR PAPERS
Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators

PGE₂ stimulates human brain natriuretic peptide expression via EP₄ and p42/44 MAPK

Hypertension and Vascular Research Division, Department of Medicine, Henry Ford Hospital, Detroit, Michigan

Submitted 23 August 2005 ; accepted in final form 13 January 2006

Brain natriuretic peptide (BNP) produced by cardiac myocytes has antifibrotic and antigrowth properties and is a marker of cardiac hypertrophy. We previously showed that prostaglandin E₂ (PGE₂) is the main prostaglandin produced in myocytes treated with proinflammatory stimuli and stimulates protein synthesis by binding to its EP₄ receptor. We hypothesized that PGE₂, acting through EP₄, also regulates BNP gene expression. We transfected neonatal ventricular myocytes with a plasmid encoding the human BNP (hBNP) promoter driving expression of a luciferase reporter gene. PGE₂ increased hBNP promoter activity 3.5-fold. An EP₄ antagonist reduced the stimulatory effect of PGE₂ but not an EP₁ antagonist. Because EP₄ signaling can involve adenylate cyclase, cAMP, and protein kinase A (PKA), we tested the effect of H-89, a PKA inhibitor, on PGE₂ stimulation of the hBNP promoter. H-89 at 5 µM decreased PGE₂ stimulation of BNP promoter activity by 100%. Because p42/44 MAPK mediates the effect of PGE₂ on protein synthesis, we also examined the role of MAPKs in the regulation of BNP promoter activity. PGE₂ stimulation of the hBNP promoter was inhibited by a MEK1/2 inhibitor and a dominant-negative mutant of Raf, indicating that p42/44 MAPK was involved. In contrast, neither a p38 MAPK inhibitor nor a JNK inhibitor reduced the stimulatory effect of PGE₂. Involvement of small GTPases was also studied. Dominant-negative Rap inhibited PGE₂ stimulation of the hBNP promoter, but dominant-negative Ras did not. We concluded that PGE₂ stimulates the BNP promoter mainly via EP₄, PKA, Rap, and p42/44 MAPK.

EP receptor; cardiac myocytes; hypertrophy; signaling pathways

This article has been cited by other articles:

				J.-Y. Qian, P. Harding, Y. Liu, E. Shesely, X.-P. Yang, and M. C. LaPointe Reduced Cardiac Remodeling and Function in Cardiac-Specific EP4 Receptor Knockout Mice With Myocardial Infarction Hypertension, February 1, 2008; 51(2): 560 - 566. [Abstract] [Full Text] [PDF]

				M. A. Frias, M. C. Rebsamen, C. Gerber-Wicht, and U. Lang Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy Cardiovasc Res, January 1, 2007; 73(1): 57 - 65. [Abstract] [Full Text] [PDF]